ID: ALA4866462
Max Phase: Preclinical
Molecular Formula: C29H39NO4
Molecular Weight: 465.63
Molecule Type: Unknown
Associated Items:
Representations
Canonical SMILES: C=C1CC[C@@H]2[C@](C)(CNCCc3cccc(OC)c3)[C@H](O)CC[C@@]2(C)[C@@H]1/C=C/C1=CCOC1=O
Standard InChI: InChI=1S/C29H39NO4/c1-20-8-11-25-28(2,24(20)10-9-22-14-17-34-27(22)32)15-12-26(31)29(25,3)19-30-16-13-21-6-5-7-23(18-21)33-4/h5-7,9-10,14,18,24-26,30-31H,1,8,11-13,15-17,19H2,2-4H3/b10-9+/t24-,25+,26-,28+,29+/m1/s1
Standard InChI Key: XVKVTNJFYZJLAT-AAZHHPOYSA-N
Molecule Features
| Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
| Molecule Type: Unknown | Topical: No | First In Class: No | Black Box: No |
| Chirality: No | Availability: No | Prodrug: No |
Drug Indications
| MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
|---|
Mechanisms of Action
| Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
|---|
Properties
| Molecular Weight: 465.63 | Molecular Weight (Monoisotopic): 465.2879 | AlogP: 4.62 | #Rotatable Bonds: 8 |
| Polar Surface Area: 67.79 | Molecular Species: BASE | HBA: 5 | HBD: 2 |
| #RO5 Violations: 0 | HBA (Lipinski): 5 | HBD (Lipinski): 2 | #RO5 Violations (Lipinski): 0 |
| CX Acidic pKa: 13.54 | CX Basic pKa: 9.97 | CX LogP: 4.56 | CX LogD: 2.07 |
| Aromatic Rings: 1 | Heavy Atoms: 34 | QED Weighted: 0.33 | Np Likeness Score: 2.23 |
References
| 1. Zhang S, Zhang Y, Fang Y, Chen H, Hao M, Tan Q, Hu C, Zhou H, Xu J, Gu Q.. (2021) Synthesis and evaluation of andrographolide derivatives as potent anti-osteoporosis agents in vitro and in vivo., 213 [PMID:33485256] [10.1016/j.ejmech.2021.113185] |
Source
Source(1):